Protocol Ledger

NCT04904588 · Phase II · ACTIVE NOT RECRUITING

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Interventional Phase II clinical trial protocol NCT04904588 sponsored by Center for International Blood and Marrow Transplant Research in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-09-30 Enrollment: 300 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04904588
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)300 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04904588
Protocol FieldVerified Registry Value
NCT IdentifierNCT04904588
Consolidated Lead SponsorCenter for International Blood and Marrow Transplant Research
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment300 participants (ESTIMATED)
Registered Start Date2021-09-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI